Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Taltz

Active ingredient: Ixekizumab

Neutral reference profile for an independent medicine-access consultancy enquiry about Taltz (Ixekizumab). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Taltz used for?

Taltz (ixekizumab) is a monoclonal antibody indicated for the treatment of people with:

  • Moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
  • Active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drug (DMARD) therapies.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Taltz identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordTaltz
Active ingredientIxekizumab
Dosage formsolution for injection
Recorded options4
Directory areaDermatology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 80 mg · 2 pre-filled syringes Catalogue organisation: LILLY DEUTSCHLAND GmbH
  2. 80 mg · 3 pre-filled syringes Catalogue organisation: LILLY DEUTSCHLAND GmbH
  3. 80 mg solution for injection · 2 pens Catalogue organisation: kohlpharma GmbH
  4. 80 mg solution for injection · 3 pens Catalogue organisation: CC Pharma GmbH

SERVICE BOUNDARY

Information checking and independent enquiry support for Taltz.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Taltz

01What is Taltz?

This directory record associates the brand name Taltz with the active ingredient Ixekizumab. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Taltz strengths and packs are recorded?

The catalogue currently shows: 80 mg · 2 pre-filled syringes; 80 mg · 3 pre-filled syringes; 80 mg solution for injection · 2 pens; 80 mg solution for injection · 3 pens. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Taltz?

Catalogue records currently name: LILLY DEUTSCHLAND GmbH, kohlpharma GmbH, CC Pharma GmbH. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Taltz?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Taltz, payment request, stock guarantee or binding offer.

06Can I buy Taltz from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.